Voss Capital Portfolio holdings
Voss Capital runs a long/short stock fund and a long-only stock fund that hunt for underfollowed companies in unusual situations. Travis Cocke, its chief investment officer, founded the firm in October 2011 after working as a portfolio manager at Farney Management and an analyst at Ascendant Advisors. The funds take relatively concentrated positions in high-conviction ideas that could double in value within three years, favouring companies where sales growth is speeding up while profit margins widen, a pairing the firm calls Voss Sauce. Its research includes interviews with management teams and competitors and a check on how well managers have allocated capital in the past.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sempra
SRE
|
+$72.7M |
| 2 |
Versigent PLC
VGNT
|
+$40.1M |
| 3 |
Rackspace Technology
RXT
|
+$29.6M |
| 4 |
Centerspace
CSR
|
+$27M |
| 5 |
Teladoc Health
TDOC
|
+$25.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Powell Industries
POWL
|
+$105M |
| 2 |
Euronet Worldwide
EEFT
|
+$62.8M |
| 3 |
Phinia Inc
PHIN
|
+$51.8M |
| 4 |
Genius Sports
GENI
|
+$32.2M |
| 5 |
Griffon
GFF
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.08% |
| 2 | Consumer Discretionary | 18.99% |
| 3 | Healthcare | 10.55% |
| 4 | Utilities | 8.77% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
CALL
Concentrix
CNXC
$1.86B
| $1.32M | 0.06% |
+60,000
| New | +$1.56M |
2026 Q2
0 quarters
|
|
52
CALL
Rigetti Computing
RGTI
$3.22B
| $966K | 0.04% |
+50,000
| New | +$967K |
2026 Q2
0 quarters
|
|
|
53
CALL
Centerspace
CSR
$991M
| $843K | 0.04% |
+15,000
| New | +$946K |
2026 Q2
0 quarters
|
|
54
CALL
Rapid7
RPD
$1.08B
| $810K | 0.04% |
+100,000
| New | +$663K |
2026 Q2
0 quarters
|
|
55
CALL
PAR Technology
PAR
$771M
| $808K | 0.04% |
46,400
-250,100
| -84% | -$3.61M |
2025 Q3
3 quarters
|
|
56
CALL
Kyndryl
KD
$3.52B
| $554K | 0.03% |
+49,000
| New | +$611K |
2026 Q2
0 quarters
|
|
57
Seer Inc
SEER
$92.5M
| $228K | 0.01% |
+137,291
| New | +$249K |
2026 Q2
0 quarters
|
|
58
Roadzen
RDZN
$87.7M
| $211K | 0.01% |
+144,254
| New | +$229K |
2026 Q2
0 quarters
|
|
59
Cognition Therapeutics
CGTX
$62.3M
| $201K | 0.01% |
175,000
-25,000
| -13% | -$29.6K |
2024 Q4
6 quarters
|
|
60
Acadia Healthcare
ACHC
$3.26B
| – | – |
-125,000
| Closed | -$2.92M | – |
|
61
CALL
Amazon
AMZN
$2.83T
| – | – |
-95,000
| Closed | -$19.8M | – |
|
62
Alexandria Real Estate Equities
ARE
$7.88B
| – | – |
-125,000
| Closed | -$5.8M | – |
|
63
CALL
FIVE9
FIVN
$2.56B
| – | – |
-50,000
| Closed | -$758K | – |
|
64
Invitation Homes
INVH
$15.8B
| – | – |
-65,000
| Closed | -$1.62M | – |
|
65
Lantern Pharma
LTRN
$8.21M
| – | – |
-50,000
| Closed | -$68.5K | – |
|
66
PUT
Omnicell
OMCL
$1.75B
| – | – |
-25,000
| Closed | -$834K | – |
|
67
CALL
uniQure
QURE
$1.47B
| – | – |
-50,000
| Closed | -$818K | – |
|
68
Regenxbio
RGNX
$477M
| – | – |
-295,787
| Closed | -$2.48M | – |
|
69
Latham Group
SWIM
$919M
| – | – |
-372,988
| Closed | -$2M | – |
|
70
Sensient Technologies
SXT
$5.17B
| – | – |
-182,974
| Closed | -$15.8M | – |
|
71
PUT
Tesla
TSLA
$1.36T
| – | – |
-222,500
| Closed | -$82.7M | – |
|
72
CALL
Xeris Biopharma Holdings
XERS
$2.35B
| – | – |
-22,500
| Closed | -$130K | – |
|
|
73
Xeris Biopharma Holdings
XERS
$2.35B
| – | – |
-1,386,927
| Closed | -$8.04M | – |
|
Similar funds
Voss Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Voss Capital held 73 positions worth $2.15B, up 14% from $1.88B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Voss Capital withdrew a net $172M in Q2 2026, closing 14 positions and reducing 22 holdings. Its most notable exit was Sensient Technologies, an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Voss Capital opened a new position in Versigent PLC worth $42.3M.
- Voss Capital's largest Q2 2026 buy was Versigent PLC: 1,007,203 shares worth $42.3M.
- Voss Capital added most to Sempra in Q2 2026, an estimated $72.7M increase.
- Voss Capital's biggest Q2 2026 reduction was Powell Industries, cutting an estimated $105M.
- Voss Capital fully exited Sensient Technologies in Q2 2026, selling an estimated $15.8M.
- Voss Capital's ten largest holdings make up 62% of its $2.15B portfolio in Q2 2026.
- Voss Capital opened 20 new positions and closed 14 in Q2 2026.
- Voss Capital's portfolio value rose 14% quarter-over-quarter to $2.15B.
Based on Voss Capital's 13F filing for Q2 2026, filed 14 Aug 2026.